A detailed history of Dryden Capital, LLC transactions in Avantor, Inc. stock. As of the latest transaction made, Dryden Capital, LLC holds 10,000 shares of AVTR stock, worth $229,899. This represents 0.6% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$229,899
% of portfolio
0.6%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$21.2 - $25.87 $212,000 - $258,700
10,000 New
10,000 $212,000
Q2 2023

Aug 14, 2023

BUY
$18.72 - $21.54 $74,880 - $86,160
4,000 Added 8.0%
54,000 $1.11 Million
Q4 2022

Feb 14, 2023

BUY
$19.22 - $22.8 $384,400 - $456,000
20,000 Added 66.67%
50,000 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$19.6 - $32.33 $588,000 - $969,900
30,000 New
30,000 $588,000

Others Institutions Holding AVTR

About Avantor, Inc.


  • Ticker AVTR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 674,035,008
  • Market Cap $15.5B
  • Description
  • Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...
More about AVTR
Track This Portfolio

Track Dryden Capital, LLC Portfolio

Follow Dryden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dryden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dryden Capital, LLC with notifications on news.